Literature DB >> 9092938

A mutation in a highly conserved region in brush-border sucrase-isomaltase and lysosomal alpha-glucosidase results in Golgi retention.

C E Moolenaar1, J Ouwendijk, M Wittpoth, H A Wisselaar, H P Hauri, L A Ginsel, H Y Naim, J A Fransen.   

Abstract

A point mutation in the cDNA of human intestinal sucrase-isomaltase has been recently identified in phenotype II of congenital sucrase-isomaltase deficiency. The mutation results in a substitution of glutamine by proline at position 1098 (Q1098P) in the sucrase subunit. Expression of this mutant sucrase-isomaltase cDNA in COS-1 cells results in an accumulation of sucrase-isomaltase in the ER, intermediate compartment and the cis-Golgi cisternae similar to the accumulation in phenotype II intestinal cells. An interesting feature of the Q1098P substitution is its location in a region of the sucrase subunit that shares striking similarities with the isomaltase subunit and other functionally related enzymes, such as human lysosomal acid alpha-glucosidase and Schwanniomyces occidentalis glucoamylase. We speculated that the Q-->P substitution in these highly conserved regions may result in a comparable accumulation. Here we examined this hypothesis using lysosomal alpha-glucosidase as a reporter gene. Mutagenesis of the glutamine residue at position 244 in the homologous region of alpha-glucosidase to proline results in a protein that is neither transported to the lysosomes nor secreted extracellularly but accumulates in the ER, intermediate compartment and cis-Golgi as a mannose-rich polypeptide similar to mutant sucrase-isomaltase in phenotype II. We propose that the Q1098P and Q244P mutations (in sucrase-isomaltase and alpha-glucosidase, respectively) generate structural alterations that are recognized by a control mechanism, operating beyond the ER in the intermediate compartment or cis-Golgi.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092938     DOI: 10.1242/jcs.110.5.557

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  9 in total

1.  Role of rubella virus glycoprotein domains in assembly of virus-like particles.

Authors:  M Garbutt; L M Law; H Chan; T C Hobman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Expression of mutant Ins2C96Y results in enhanced tubule formation causing enlargement of pre-Golgi intermediates of CHO cells.

Authors:  Jing-Yu Fan; Jürgen Roth; Christian Zuber
Journal:  Histochem Cell Biol       Date:  2007-07-24       Impact factor: 4.304

3.  Congenital sucrase-isomaltase deficiency arising from cleavage and secretion of a mutant form of the enzyme.

Authors:  R Jacob; K P Zimmer; J Schmitz; H Y Naim
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 4.  Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

5.  Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in {beta}-cells.

Authors:  Mirko Trajkovski; Hassan Mziaut; Anke Altkrüger; Joke Ouwendijk; Klaus-Peter Knoch; Stefan Müller; Michele Solimena
Journal:  J Cell Biol       Date:  2004-12-13       Impact factor: 10.539

6.  Rab2A is a pivotal switch protein that promotes either secretion or ER-associated degradation of (pro)insulin in insulin-secreting cells.

Authors:  Taichi Sugawara; Fumi Kano; Masayuki Murata
Journal:  Sci Rep       Date:  2014-11-07       Impact factor: 4.379

7.  Heterozygotes Are a Potential New Entity among Homozygotes and Compound Heterozygotes in Congenital Sucrase-Isomaltase Deficiency.

Authors:  Diab M Husein; Dalanda Wanes; Lara M Marten; Klaus-Peter Zimmer; Hassan Y Naim
Journal:  Nutrients       Date:  2019-09-25       Impact factor: 5.717

8.  Differential Effects of Sucrase-Isomaltase Mutants on Its Trafficking and Function in Irritable Bowel Syndrome: Similarities to Congenital Sucrase-Isomaltase Deficiency.

Authors:  Diab M Husein; Sandra Rizk; Hassan Y Naim
Journal:  Nutrients       Date:  2020-12-22       Impact factor: 5.717

9.  An HRD/DER-independent ER quality control mechanism involves Rsp5p-dependent ubiquitination and ER-Golgi transport.

Authors:  Cole M Haynes; Sabrina Caldwell; Antony A Cooper
Journal:  J Cell Biol       Date:  2002-07-08       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.